Clinical-stage biotech developing treatments for rare metabolic genetic diseases.
Industry: Health Care
First Day Return: +101.2%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 11/08/2013 |
Offer Price | $21.00 |
Price Range $19.00 - $20.00 | |
Offer Shares (mm) | 5.8 |
Deal Size ($mm) | $121 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 01/30/2014 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $121 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Novato, CA, United States |
Founded | 2010 |
Employees at IPO | 59 |
Website www.ultragenyx.com |